BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
Go back to BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)| (NASDAQ: FDMT) | Delayed: 12.19 +0.54 (4.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.65 | 52 Week High | $ | |||
| Open | $11.63 | 52 Week Low | $ | |||
| Day High | $12.35 | P/E | N/A | |||
| Day Low | $11.26 | EPS | $ | |||
| Volume | 773,765 | |||||

